Executive action has taken place to stop the publication of studies on the growing bird flu outbreak by exerting unprecedented influence on the “voice of the CDC”, the Morbidity and Mortality Weekly Report, as the virus spreads through wild birds, poultry farms, and livestock nationwide

 

Restrictions on Language and Research Publication:

Reports indicate that the CDC has been ordered to retract or pause the publication of research manuscripts containing specific terms related to gender and sexuality. This is due to executive actions that seek to define sex as a binary biological classification.

This restriction impacts the CDC's ability to accurately report on studies that involve diverse populations, as it limits the use of essential demographic information.

​

Impact on Clinical Trial Diversity:

Executive orders restricting diversity, equity, and inclusion (DEI) programs have led to the removal of FDA draft guidance on clinical trial diversity.

This raises concerns about the representation of diverse populations in clinical research, which is crucial for ensuring that medical treatments are effective for everyone.

​

Changes to Global Health Initiatives:

Executive actions have also resulted in changes to U.S. involvement in global health organizations and programs, including those related to the World Health Organization (WHO).

These changes involve pausing funding, reassigning personnel, and reviewing foreign aid programs, which can disrupt ongoing public health initiatives.